ConcertAI Nabs $150M Series C To Scale Real-World Data And Cancer Research Tools

A $150 million Series C funding round fueled by global investment firm Sixth Street has lifted Boston-based Concert AI’s valuation to $1.9 billion. The company now has additional resources to back further scaling of its cancer research software and real-world data (RWD) solutions...